Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

ITI Pharma and Healthcare Fund · Regular ✕Baroda BNP Paribas ESG Best-in-Class Strategy Fund · Regular ✕

Growth of ₹10,000

Basics

ITI Pharma and Healthcare FundBaroda BNP Paribas ESG Best-in-Class Strategy Fund
CategorySectoral / ThematicSectoral / Thematic
PlanRegularRegular
Fund houseITIBaroda BNP
NAV₹18.7412₹10.7822
NAV date20 Nov 202620 Nov 2026
History5.0 years9 months
Expense ratio2.6%2.7%
Stars★★★★★Not rated
Growth Score68.80—

Returns

ITI Pharma and Healthcare FundBaroda BNP Paribas ESG Best-in-Class Strategy Fund
1 month+11.19%+9.56%
3 months+3.97%+1.27%
6 months+11.37%+5.81%
YTD+19.43%—
1 year+15.93%—
3 years (CAGR)+17.74%—
5 years (CAGR)+13.47%—
10 years (CAGR)——
Since launch+13.30%+7.64%

Risk

ITI Pharma and Healthcare FundBaroda BNP Paribas ESG Best-in-Class Strategy Fund
Volatility15.9%—
Downside volatility10.3%—
Sharpe0.71—
Sortino1.09—
Calmar1.01—
Return / risk1.12—
Deepest fall−18.53%−10.40%
Days to recover38443
Below its high+0.00%+0.00%

Against benchmark

ITI Pharma and Healthcare FundBaroda BNP Paribas ESG Best-in-Class Strategy Fund
Alpha−3.15%—
Beta0.98—
R²84.6%—
Up capture90.7%—
Down capture104.0%—
Tracking error6.2%—
Information ratio−0.56—
Treynor0.10—

Consistency

ITI Pharma and Healthcare FundBaroda BNP Paribas ESG Best-in-Class Strategy Fund
Best 1-year+58.89%—
Middle 1-year+13.39%—
Worst 1-year−11.02%—
1-year periods with a loss25.6%—
Middle 3-year+19.00%—
Positive months69.4%—
Best day+3.48%+2.40%
Worst day−3.29%−1.90%
Worst 5% day−1.48%−1.11%
Positive days55.6%53.7%
NAVs a year247176

SIP of ₹10,000 a month

ITI Pharma and Healthcare FundBaroda BNP Paribas ESG Best-in-Class Strategy Fund
5-year XIRR——
5-year value——
3-year XIRR+13.53%—
1-year XIRR+25.62%—

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth